Medicare outlines plan to expand coverage for costly new Alzheimer’s drugs

Medicare officials outlined plans Thursday to broadly cover a new class of Alzheimer’s drugs amid an intense lobbying campaign by patient advocates and drugmakers to ensure access to the first medications shown to slow cognitive decline from the disease.